what drugs are glp 1 agonists comparison of Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review Clinical Focus on GLP-1 Agonists

Pfizer expects to have its first weight-loss treatment on the market by the end of 2028, a move that could position it to capture a share of what Bourla called a "huge" market, estimated at approximately $150 to $200 billion

GLP-1 RAs, such as semaglutide and tirzepatide, may also help improve metabolic health in patients with PCOS by promoting weight loss, improving insulin sensitivity, and reducing blood glucose levels ( 4 , 6 , 14 )

It is recommended for adults and adolescents in Las Vegas and Reno whose weight loss has been complicated by hormone imbalance, insulin resistance, or slowed metabolism, and is provided by board-certified obesity medicine specialists

GLP-1s are a class of diabetes medications that imitate the natural hormone glucagon-like peptide-1

This guidance specifically notes that patients may not readily disclose off-label aesthetic use of these medications, highlighting the importance of comprehensive medication histories [45]